$MGTX SEC Filings

Filed On	Filing
20 Oct 2026	Form 4: Giroux Richard, CFO & COO Sold 56,000 shares ($557K)
20 Oct 2026	144
06 Oct 2026	Form 4: Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY Sold 27,659 shares ($294K)
06 Oct 2026	144
24 Sep 2026	Form 4: Sebulsky Alan, Director Granted 100,000 Restricted Share Units
24 Sep 2026	Form 3: Sebulsky Alan, Director Holds 34,500 shares of Ordinary Shares
23 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure LONDON and NEW YORK, September 23, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced the appointment of Alan M. Sebulsky to its Board of Dire...
18 Aug 2026	Form 4: Forbes Alexandria, Director Sold 62,000 shares ($859K)
18 Aug 2026	144
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	S-8
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition
21 Jul 2026	Form 4: Giroux Richard, CFO & COO Sold 56,000 shares ($701K)
21 Jul 2026	144
07 Jul 2026	Form 4: Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY Sold 27,659 shares ($409K)
07 Jul 2026	144
07 Jul 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more
29 Jun 2026	Form 4: Wollin Robert J, GENERAL COUNSEL AND SECRETARY Granted 100,000 Restricted Share Units
29 Jun 2026	Form 4: Zeldin Robert K, CHIEF MEDICAL OFFICER Granted 100,000 Restricted Share Units

Comments